— Know what they know.
Not Investment Advice

ONBI OTC

ONE Bio Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +150.0% 3Y: -90.0% 5Y: -98.2%
$0.00
+0.00 (+0.00%)
 
OTC · Basic Materials · Chemicals - Specialty · Tech Score Neutral · Power 53 · $4236 mcap · 8M float · 0.069% daily turnover

Balance Sheet Trends

Total Assets
$70M +28.3% ▲
5Y CAGR: +283.2%
Total Liabilities
$27M +27.6% ▲
5Y CAGR: +256.0%
Shareholders Equity
$42M +43.0% ▲
5Y CAGR: +309.2%
Cash & Investments
$11M +116.6% ▲
5Y CAGR: +252.6%
Total Debt
$20M +15.4% ▲
5Y CAGR: +245.7%
Net Debt
$9M -25.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2006FY2007FY2008FY2009FY2010
— Assets —
Cash$11K$141K$2K$5M$11M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$11K$141K$2K$5M$11M
Net Receivables$57K$45K$26K$16M$20M
Inventory$0$0$0$3M$5M
Other Current Assets$0$0$0$0$0
Total Current Assets$67K$177K$28K$28M$40M
Property, Plant & Equip.$43K$17K$11K$6M$9M
Goodwill & Intangibles$0$0$12K$6M$4M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$12K$0-$833$16M$18M
Total Non-Current Assets$55K$17K$23K$27M$30M
Total Assets$122K$195K$51K$55M$70M
— Liabilities —
Accounts Payable$2K$6K$10K$2M$4M
Short-Term Debt$18K$8K$9K$13M$19M
Deferred Revenue$0$0$0$63K$65K
Other Current Liabilities$28K$29K$43K$0$216K
Total Current Liabilities$57K$23K$62K$17M$27M
Long-Term Debt$31K$23K$15K$4M$592K
Other Non-Current Liab.$0-$858-$15K$0$0
Total Non-Current Liabilities$31K$109K$15K$4M$572K
Total Liabilities$88K$131K$77K$22M$27M
— Equity —
Common Stock$14K$17K$1M$29K$7K
Retained Earnings-$6K-$126K-$74K$10M$17M
Accumulated OCI$0$0$0$1M$5M
Total Stockholders Equity$35K$63K-$26K$29M$42M
Total Liabilities & Equity$122K$195K$51K$55M$70M
— Key Metrics —
Total Debt$48K$83K$24K$17M$20M
Net Debt$38K-$58K$21K$12M$9M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms